Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The Cox model: limitations and extensions].

C Quantin1, B Asselain, T Moreau

  • 1C.H.R.U., Service d'informatique médicale 2, Dijon.

Revue D'Epidemiologie Et De Sante Publique
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Hospitalization for Eating Disorders and Related Suicidal Risk, Following COVID-19 Pandemic.

Depression and anxiety·2026
Same author

Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018).

ESMO real world data and digital oncology·2026
Same author

Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO).

ESMO open·2025
Same author

Reliability of a French hospital administrative database to measure self-harm in epidemiology studies.

General hospital psychiatry·2024
Same author

Author reply.

BJOG : an international journal of obstetrics and gynaecology·2024
Same author

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same journal

[Advocacy and recommendations for better positioning of epidemiologists during future epidemics and pandemics].

Revue d'epidemiologie et de sante publique·2024
Same journal

Vient de paraître.

Revue d'epidemiologie et de sante publique·2024
Same journal

Revue d'epidemiologie et de sante publique·2024
Same journal

Vient de paraître.

Revue d'epidemiologie et de sante publique·2024
Same journal

VIENT DE PARAÎTRE.

Revue d'epidemiologie et de sante publique·2024
Same journal

Revue d'epidemiologie et de sante publique·2024
See all related articles

The proportional hazards model has limitations and may not fit all data. This review covers its limits, goodness-of-fit tests, and potential extensions for survival analysis.

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Statistical Modeling

Context:

  • The proportional hazards model (Cox's model) is a widely used statistical method for analyzing survival data.
  • However, its assumptions are frequently violated in real-world applications, limiting its utility.
  • Assessing model fit is crucial for reliable survival data interpretation.

Purpose:

  • To review the limitations of the proportional hazards model.
  • To discuss key goodness-of-fit techniques for evaluating survival models.
  • To explore potential extensions and alternative approaches to survival analysis.

Summary:

  • The proportional hazards model, while popular, often fails to adequately represent complex survival data.
  • Key methods for assessing the goodness-of-fit of this model are presented.

Related Experiment Videos

  • The abstract also outlines avenues for extending proportional hazards analysis to better accommodate diverse data structures.

    • Impact:

    • Provides researchers with a critical understanding of the proportional hazards model's constraints.
    • Offers practical guidance on model validation using goodness-of-fit techniques.
    • Highlights future directions for advanced survival data analysis.